S. 4411

S. 4411: A bill to clarify eligibility for small business loans, and for other purposes.

Introduced Edward Markey (D) SENATE_BILL — 119th Congress
Plain English Summary

The Investing in the American Dream Act, introduced by Senator Edward J. Markey on April 28, 2026, aims to expand eligibility for Small Business Administration (SBA) loans to include small businesses that are at least 51% owned and controlled by certain legally present, work-authorized non-U.S. citizens. This includes lawful permanent residents (green card holders), refugees, asylees, and individuals with specific deferred action statuses. The bill seeks to address recent SBA rules that restricted loan access for many noncitizen business owners, thereby supporting immigrant entrepreneurs who contribute significantly to the U.S. economy.

Positive Media Summary

Supporters of the Investing in the American Dream Act argue that it will bolster the U.S. economy by enabling immigrant entrepreneurs to access essential capital for starting and expanding businesses. They highlight that immigrants own a substantial portion of employer firms and contribute significantly to job creation. By clarifying loan eligibility, the bill is seen as a step toward economic inclusivity and growth.

Negative Media Summary

Critics of the bill contend that taxpayer-backed loan guarantees should be reserved for U.S. citizens and nationals. They express concerns that expanding eligibility to noncitizens could increase the risk of loan defaults and potential misuse of funds. Additionally, opponents argue that the bill might complicate the administration of SBA loans and divert resources from citizen-owned businesses.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Commerce

There are no direct overlaps between Senator Edward Markey's top donors and the subject matter of the bill S. 4411, which pertains to small business loans. This suggests a low risk of direct financial conflict of interest. However, there is significant lobbying activity in the bill's policy area, with several entities lobbying via The McKeon Group, Inc. and others. The total disclosed lobbying expenditure related to this bill's policy area is $630,000. While these lobbying activities indicate interest in the bill's policy area, without more specific information about the lobbyists' objectives or connections to Senator Markey, it is not possible to definitively identify a conflict of interest. It is important for voters to be aware of this lobbying activity and to seek transparency about the lobbyists' objectives and any potential connections to lawmakers.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
BAE, KIM & LEE, LLC THE MCKEON GROUP, INC. $370,000
MBK PARTNERS THE MCKEON GROUP, INC. $150,000
B. BRAUN MEDICAL INC. POLSINELLI PC $70,000
VECTOR THE MCKEON GROUP, INC. $40,000
SOLUTION PHILIPPINES, LLC THE MCKEON GROUP, INC. $40,000
AMERICAN PHARMACISTS ASSOCIATION AMERICAN PHARMACISTS ASSOCIATION $35,000
D-WAVE GOVERNMENT, INC THE MCKEON GROUP, INC. $10,000
NATIONAL ASSOCIATION OF RSVP PROGRAM DIRECTORS THE SUSQUEHANNA GROUP $5,000
ROWAN UNIVERSITY ROWAN UNIVERSITY undisclosed
STR8 CORPORATION BRODY GROUP L.L.C. PUBLIC AFFAIRS undisclosed
WEST GULF MARITIME ASSOCIATION WEST GULF MARITIME ASSOCIATION undisclosed
CENTRAL ADMIXTURE PHARMACY SERVICES, INC. POLSINELLI PC undisclosed
CARTRIDGE TECHNOLOGIES, LLC CHECKMATE GOVERNMENT RELATIONS undisclosed
BLUE DIAMOND ATOMICS NATURAL STATE CONSULTING AND STRATEGIES undisclosed
POPLICUS INCORPORATED DBA GOVINI CHECKMATE GOVERNMENT RELATIONS undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Edward Markey, ranked by total contributions.

Health Professionals $240,000,000
Individuals: $240,000,000 PACs: $0
Retired $75,000,000
Individuals: $75,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us